Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares OutstandingShares Outstanding
Ratios

Trulieve Cannabis (TCNNF) EBIAT (2020 - 2026)

Trulieve Cannabis has reported EBIAT over the past 6 years, most recently at -$38.0 million for Q4 2025.

  • For Q4 2025, EBIAT rose 31.14% year-over-year to -$38.0 million; the TTM value through Dec 2025 reached -$112.4 million, up 26.32%, while the annual FY2025 figure was -$116.6 million, 24.69% up from the prior year.
  • EBIAT for Q4 2025 was -$38.0 million at Trulieve Cannabis, down from -$28.8 million in the prior quarter.
  • Over five years, EBIAT peaked at $40.9 million in Q2 2021 and troughed at -$406.9 million in Q2 2023.
  • A 5-year average of -$50.3 million and a median of -$32.3 million in 2022 define the central range for EBIAT.
  • On a YoY basis, EBIAT climbed as much as 115.86% in 2021 and fell as far as 2042.4% in 2021.
  • Year by year, EBIAT stood at -$59.0 million in 2021, then fell by 13.09% to -$66.8 million in 2022, then soared by 47.9% to -$34.8 million in 2023, then plummeted by 58.55% to -$55.2 million in 2024, then surged by 31.14% to -$38.0 million in 2025.
  • Business Quant data shows EBIAT for TCNNF at -$38.0 million in Q4 2025, -$28.8 million in Q3 2025, and -$13.5 million in Q2 2025.